PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10411913-7	1999	With K14-CreER(tam), postnatal transgenic mice show no Cre activity until tamoxifen is administered.	Tamoxifen	74-83	keratin 14	Mus musculus	5-8	
11595821-5	2000	Furthermore, Tamoxifen administration to adult K14-Cre-ER(T2) mice efficiently induced recombination in the basal keratinocytes, whereas no background recombination was detected in the absence of ligand treatment.	Tamoxifen	13-22	keratin 14	Mus musculus	47-50	
19435901-3	2009	Here, we have developed an inducible oral-specific animal tumor model system, which consists in the expression of a tamoxifen-inducible Cre recombinase (CreER(tam)) under the control of the cytokeratin 14 (K14) promoter (K14-CreER(tam)) and mice in which the endogenous K-ras locus is targeted (LSL-K-ras(G12D)), thereby causing the expression of endogenous levels of oncogenic K-ras(G12D) following removal of a stop element.	Tamoxifen	116-125	keratin 14	Mus musculus	190-204	
35409002-6	2022	Here, we used an inducible oral-specific mouse model, where the expression of a tamoxifen-inducible Cre recombinase (CreERtam), which is under the control of the cytokeratin 14 promoter (K14-CreERtam), induces the expression of the K-ras oncogenic variant KrasG12D (LSLK-rasG12D).	Tamoxifen	80-89	keratin 14	Mus musculus	162-176	
29758119-2	2018	To do so, we developed tamoxifen-inducible double mutant (K-rasG12D -expressing and Ppp6c-deficient) mice in which K-rasG12D expression is driven by the cytokeratin 14 (K14) promoter.	Tamoxifen	23-32	keratin 14	Mus musculus	153-167	
24342142-7	2014	A similar pattern of lncRNA profiling is observed in the epidermis of K14 driven, tamoxifen-regulated epidermal-specific VDR null vs. wild-type control mice.	Tamoxifen	82-91	keratin 14	Mus musculus	70-73	
34407449-4	2022	In the present study, Krt14-cre/ERT-Kras transgenic mice were developed and the expression of K-RasG12D was induced by tamoxifen.	Tamoxifen	119-128	keratin 14	Mus musculus	22-27